Grant - Therini Bio
Investment Firm
Overview
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Announced Date
Jan 01, 2023
Funding Type
Grant
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Therini Bio raised $3000000 on 2023-01-01 in Grant
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 08, 2019 |  Seed Round - Therini Bio | 2 | - | 9.3M |
| May 10, 2021 | Seed Round - Therini Bio | 6 | - | 17.0M |
| Apr 27, 2023 | Series A - Therini Bio | 8 | - | 36.0M |
| Jan 01, 2023 | Grant - Therini Bio | 1 | - | 3.0M |
Recent Activity
There is no recent news or activity for this profile.